“Health donors, policymakers, and practitioners continuously make life-and-death decisions about which type of patients receive what interventions, when, and at what cost. These decisions—as consequential as they are— often result from ad hoc, nontransparent processes driven more by inertia

iDSI aims to help policymakers in low and middle income countries in building capacity for active priority-setting, such that they can spend limited health budgets in a more efficient and equitable way, and achieve sustainable universal health coverage (UHC). In order to help achieve iDSI this aim,

The use of off-label medicines is an unexplored area for healthcare priority setting, though it is common practice in countries and can have a significant positive or negative effect on health outcomes and the efficiency of health care systems. It is therefore important to have a rational an

WASHINGTON — Is the world on the verge of ending the AIDS epidemic and creating an AIDS-free generation, even though a cure and a vaccine are still distant hopes?Yes, roared enthusiasts among the nearly 24,000 participants at the 19th International AIDS Conference here last week. Their hopes are bas

(Reuters) – Europe’s medicines regulator, criticised in the past for excessive secrecy, is opening its data vaults to systematic scrutiny in a move that will let independent researchers trawl through millions of pages of clinical trial information.The change is a landmark in transparency that puts E

HITAP team facilitated a two and a half day workshop in Kathmandu, Nepal on March 30 – April 1, 2015 at the request of the Nepalese Ministry of Health and Population (MoHP). The goal of the workshop was to explore the potential application of health and technology assessment (HTA) to evaluate and in

Epidemiological modelling is an important tool to help public health planners understand potential disease outcomes in the population. The recent visibility of models and their perceived influence in the decision-making processes surrounding the response to the COVID-19 pandemic has led to a great d

Vietnam has decided to incorporate Health Technology Assessment (HTA) evidence to support reimbursement decisions for medicines and has recognised the need for standard guidelines for both the process and the methodological aspects of HTA. The Health Strategy and Policy Institute (HSPI), Ministry o

CATHERINE PITTa,* ANNA VASSALLa, YOT TEERAWATTANANONb, ULLA K. GRIFFITHSa, LORNA GUINNESSa, AMIAN WALKERc, NICOLA FOSTERd and KARA HANSONa a Department of Global Health & Development, London School of Hygiene & Tropical Medicine, London, UK b Health Intervention and Technology Assess

Economic evidence is increasingly being used for informing health policies. However, the underlining principles of health economic analyses are not always fully understood by non-health economists, and inappropriate types of analyses, as well as inconsistent methodologies, may be being used for info